Primary Ewing sarcoma of the brain: a case report and literature review
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2007 · 1 min read
In brief
In brief
This case report describes a rare primary CNS Ewing sarcoma in a 7-year-old with an anterior cranial fossa mass, confirmed by CD99 positivity and EWS-FLI1 fusion detection. The authors emphasize that molecular testing distinguishes CNS-EES from morphologically similar central PNETs, guiding appropriate treatment decisions.
Written by the GCMD Library team from the article.
Statements in this article
Ewing sarcoma and peripheral primitive neuroectodermal tumor share clinicopathologic and molecular genetic features, including characteristic chromosomal translocation resulting in fusion of the EWS gene on 22q12 to either the FLI1 gene on 11q24 or other Ets family transcription factor genes such as the ERG gene on 21q22.
The characteristic EWS gene translocations found in Ewing sarcoma are not found in central primitive neuroectodermal tumors such as medulloblastoma and supratentorial PNET.
Ewing sarcoma has only rarely been noted to primarily involve the central nervous system as extraosseous Ewing sarcoma (CNS-EES).
Positive membranous immunostaining for CD99 and demonstration of EWS-FLI1 fusion by fluorescence in situ hybridization studies confirm the diagnosis of CNS-EES.
CNS-EES may look identical to central primitive neuroectodermal tumors but differs in histogenesis, molecular characteristics, and clinical behavior.
Demonstration of characteristic translocations by molecular studies differentiates CNS-EES from cPNET and helps clinicians make informed decisions regarding therapy.